Page 463 - TBE_Book_V2_2019

Chapter 14: Prevention

Contact: eva.poellabauer@meduniwien.ac.at 7. Schuller E, Klade CS, Heinz FX, et al. Effect of
pre-existing anti-tick-borne encephalitis
virus immunity on neutralising antibody
Citation:
response to the Vero cell-derived,
Pöllabauer EM, Kollaritsch H. Prevention: inactivated Japanese encephalitis virus
vaccine candidate IC51. Vaccine.
Vaccines and Immunoglubins. Chapter 14. In:
2008;26:6151-6.
Dobler G, Erber W, Bröker M, Schmitt HJ, eds.
The TBE Book. Singapore: Global Health Press; 8. Demicheli V, Debalini MG, Rivetti A.
2019 (2nd edition). doi: 10.33442/978-981-14 Vaccines for preventing tick-borne
-0914-1_14 encephalitis. Cochrane Database Syst Rev.
2009:CD000977.

References 9. Loew-Baselli A, Poellabauer EM, Pavlova BG,
et al. Prevention of tick-borne encephalitis
by FSME-IMMUN® vaccines: review of a
1. Klockmann U, Bock HL, Franke V, Hein B,
Reiner G, Hilfenhaus J. Preclinical investigations clinical development programme. Vaccine.
of the safety, immunogenicity and efficacy of a 2011;29:7307- 19.
purified, inactivated tick-borne encephalitis
10. Ehrlich HJ, Pavlova BG, Fritsch S, et al.
vaccine. J Biol Stand. 1989;17:331-42.
Randomized, phase II dose-finding studies of a
modified tick-borne encephalitis vaccine:
2. Girgsdies OE, Rosenkranz G. Tick-
evaluation of safety and immunogenicity.
borne encephalitis: development
Vaccine. 2003;22:217-23.
of a paediatric vaccine. A
controlled, randomized, double-
11. Loew-Baselli A, Konior R, Pavlova BG, et al.
blind and multicentre study.
Safety and immunogenicity of the modified
Vaccine. 1996;14:1421-8.
adult tick-borne encephalitis vaccine FSME-
IMMUN: results of two large phase 3 clinical
3. Vorob’eva MS, Rasshchepkina MN,
studies. Vaccine. 2006;24:5256-63.
Ladyzhenskaia IP. [Vaccines, immunoglobulins,
and test systems for the prevention and
12. Schöndorf I, Beran J, Cizkova D, Lesna V,
diagnosis of tick-borne encephalitis]. Vopr
Banzhoff A, Zent O. Tick-borne
Virusol. 2007;52:30-6.
encephalitis (TBE) vaccination: applying
the most suitable vaccination schedule.
4. Pavlova LI, Gorbunov MA, Vorob’eva MS,
et al. [A cultured concentrated inactivated Vaccine. 2007;25:1470-5.
vaccine against tick-borne encephalitis
studied during the immunization of 13. Pöllabauer EM, Fritsch S, Pavlova BG, et al.
children and adolescents]. Zh Mikrobiol Clinical evaluation to determine the
appropriate paediatric formulation of a tick-
Epidemiol Immunobiol. 1999:50-3
borne encephalitis vaccine. Vaccine.
2010;28:4558-65.
5. Lu Z, Bröker M, Liang G. Tick-borne
encephalitis in mainland China. Vector
Borne Zoonotic Dis. 2008;8:713-20. 14. Pöllabauer EM, Pavlova BG, Löw-Baselli A,
et al. Comparison of immunogenicity and
safety between two paediatric TBE
6. Xing Y, Schmitt HJ, Arguedas A, Yang J. Tick-
borne encephalitis in China: A review of vaccines. Vaccine. 2010;28:4680-5.
epidemiology and vaccines. Vaccine.
2017;35:1227-37.

465
458